ProPhase Labs Stock Price (NASDAQ:PRPH)

Add to My Stocks
$3.01 $0.01 (0.33%) PRPH stock closing price Sep 18, 2018 (Closing)
Prev Close* : $3
Market Cap:
$34.63M
Day Low: $3.01
52 Week Low: $2.03
Open: $3.02
Volume: -
Day High: $3.05
52 Week High: $6.64
Dividend:
0.00

Latest Stock Market News

Latest Articles

ProPhase Labs News - From Partners

ProPhase Establishes 3.2 Million Share Equity Line   by Marketwired on Aug 05, 2015

PRPH Stockcharts

View PRPH PE ratio, PS ratio stocks charts and compare with peers.
PRPH Chart
Note: Compare ProPhase Labs stock price history with the index and industry peers.

ProPhase Labs Valuation

PE ratio
(price earnings ratio)
10.58
PS ratio (
price to sales ratio
)
2.47
PB ratio (
price to book ratio
)
1

ProPhase Labs Returns

ROE
(return on equity)
-2%

ProPhase Labs Financial Ratios

Asset Turnover
0.45
Receivables Turnover
2.87
Debt to Equity
0
Dividend Yield
33.28%

PRPH Industry Peers

Company Price Change (%)
India Globalization Capital (IGC)1.410.33 (30.56%)
Lipocine (LPCN)1.580.01 (0.64%)
Nutrafuels (NTFU)0.20 (0%)
Mannatech (MTEX)20.10.15 (0.74%)
Usana Health Sciences (USNA)124.10.15 (0.12%)
Nutrafuels (NTFU)0.20 (0%)
Cyanotech (CYAN)3.670.23 (5.9%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

ProPhase Labs Inc Stock News - Partner Headlines

ProPhase Labs Financial Statements

income statement20172016201520142013
Net Sales or Revenues9.86M21.01M20.6M22.07M25.03M
Net Income41.83M-2.86M-3.6M-7.83M-
Total Operating Expense5.5M12.14M15.75M22M15.43M
View ProPhase Labs income statement
balance sheet20172016201520142013
Total Assets34.16M12.8M14.82M16.05M17.42M
Total Liabilities1.07M6.84M6M5.34M4.82M
Shareholders Equity33.08M5.96M8.82M10.71M12.59M
View ProPhase Labs balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.42M1.94M-0.39M-0.27M-
Net Cash from (used by) Operating Activities-2.83M-0.47M-3.49M-3.21M1.13M
Increase (Decrease) in Prop Plant And Equipment-0.2M-0.65M-0.7M-0.3M-0.44M
View ProPhase Labs cash flow statement

ProPhase Labs Stock Message Board

As of last trading day, ProPhase Labs stock price was $3.01. Looking at ProPhase Labs market capitalization, which currently stands at $34.63M, we can say that PRPH stock is a Nano Cap stock. A value investor must look at the fundamentals of a stock, and perform ProPhase Labs valuation, even though in the short-term, sentiment and current breaking news might affect ProPhase Labs stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy PRPH stock than sell it, then ProPhase Labs stock price goes up. Conversely, if more investors wanted to sell PRPH stock than buy it, there would be greater supply than demand, and the stock price would fall. 1,102 shares were traded with a closing stock price of $3.01 as of Sep 18, 2018, as can be seen from ProPhase Labs stock quote. One can view ProPhase Labs stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. ProPhase Labs stock dividend was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking ProPhase Labs stock price history.